Abstract
Background: Prostate cancer (PC) is the most diagnosed cancer in men and the fifth leading cause of cancer deaths globally. Evaluation of PC clinical trials should measure outcomes from survivability to quality of life. A Core Outcome Set (COS) provides a standardized set of outcomes to be reported in clinical trials within a specific field. They are developed through the consensus of stakeholders including patients, physicians, and researchers. Following COSs in PC ensures important outcomes are measured to improve comparability and selection of PC treatment. Our objective is to evaluate the knowledge, perception, and use of COSs by trialists in PC.
Methods: Using ClinicalTrials.gov, we identified trialists and extracted their names and emails. Surveys were sent on 1/2/24 and open for eight weeks with reminders sent every two weeks to trialists who did not complete the survey. Surveys collected trialist demographic information and familiarity with PC COSs. Trialists less familiar with COSs were directed to questions that gauged interest and need for further COS information. Trialists familiar with COSs were directed to questions addressing their experiences, challenges, and suggestions for PC COSs. Survey results consisted of both qualitative and quantitative data. Analysis will include descriptive statistics for trialists demographics, thematic analysis for qualitative data, and inferential statistics for subgroup analysis.
Results: Survey response collection and data analysis are currently ongoing in our study. Our results will include descriptive statistics for trialists demographics, thematic analysis for qualitative data, and inferential statistics for subgroup analysis.
Conclusion: After the survey collection period and data analysis, our results will help us understand PC clinical trialists knowledge, perception, and use of relevant COSs. Our results could be used to identify where efforts should be best directed to promote education and adoption of relevant PC COSs.
Methods: Using ClinicalTrials.gov, we identified trialists and extracted their names and emails. Surveys were sent on 1/2/24 and open for eight weeks with reminders sent every two weeks to trialists who did not complete the survey. Surveys collected trialist demographic information and familiarity with PC COSs. Trialists less familiar with COSs were directed to questions that gauged interest and need for further COS information. Trialists familiar with COSs were directed to questions addressing their experiences, challenges, and suggestions for PC COSs. Survey results consisted of both qualitative and quantitative data. Analysis will include descriptive statistics for trialists demographics, thematic analysis for qualitative data, and inferential statistics for subgroup analysis.
Results: Survey response collection and data analysis are currently ongoing in our study. Our results will include descriptive statistics for trialists demographics, thematic analysis for qualitative data, and inferential statistics for subgroup analysis.
Conclusion: After the survey collection period and data analysis, our results will help us understand PC clinical trialists knowledge, perception, and use of relevant COSs. Our results could be used to identify where efforts should be best directed to promote education and adoption of relevant PC COSs.
| Original language | American English |
|---|---|
| Pages | 54 |
| State | Published - 16 Feb 2024 |
| Event | Oklahoma State University Center for Health Sciences Research Week 2024 - Oklahoma State University Center for Health Sciences, Tulsa, United States Duration: 13 Feb 2024 → 17 Feb 2024 https://medicine.okstate.edu/research/research_days.html |
Conference
| Conference | Oklahoma State University Center for Health Sciences Research Week 2024 |
|---|---|
| Country/Territory | United States |
| City | Tulsa |
| Period | 13/02/24 → 17/02/24 |
| Internet address |
Keywords
- Prostate cancer
- clinical trials
- core outcome sets